ATUL2021-04-012021-06-30in-bse-fin:OneOperatingExpenses01Member ATUL2021-04-012021-06-30in-bse-fin:OneOperatingExpenses02Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentRevenue01Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentRevenue02Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentRevenue03Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentResults01Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentResults02Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentResults03Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentAssets01Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentAssets02Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentAssets03Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentLiabilities01Member ATUL2021-06-30in-bse-fin:OneReportableSegmentLiabilities01Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentLiabilities02Member ATUL2021-06-30in-bse-fin:OneReportableSegmentLiabilities02Member ATUL2021-04-012021-06-30in-bse-fin:OneReportableSegmentLiabilities03Member ATUL2021-06-30in-bse-fin:OneReportableSegmentLiabilities03Member ATUL2021-04-012021-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ATUL2021-04-012021-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ATUL2021-04-012021-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member ATUL2021-04-012021-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares ATUL 2021-04-01 2022-03-31 2021-06-30 INR Crores First quarter Multi segment 2021-04-01 2021-06-30 Unaudited Consolidated 10802000000.00 296200000.00 11098200000.00 5393700000.00 418000000.00 -628600000.00 796200000.00 20600000.00 432600000.00 2461600000.00 8894100000.00 2204100000.00 0.00 2204100000.00 541100000.00 30900000.00 572000000.00 0.00 1632100000.00 0.00 0.00 0.00 19400000.00 1651500000.00 1309000000.00 2960500000.00 1309000000.00 0.00 2968400000.00 -7900000.00 295900000.00 10 56.09 56.09 0.00 0.00 56.09 56.09 Notes: 1. These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. 2. These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on July 22, 2021, and approved by the Board of Directors at its meeting held on July 23, 2021, through video conferencing. In accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the statutory auditors have carried out a limited review of the consolidated unaudited financial results for the quarter ended on June 30, 2021. The Statutory Auditors report does not have any qualification / modification. 3. The Company has reported Segment information as per the Ind AS 108, 'Operating Segments', as below: Name of segment Main product groups Life Science Chemicals APIs, API intermediates, Fungicides, Herbicides Performance and Other Chemicals Adhesion promoters, Bulk chemicals, Epoxy resins and hardeners, Intermediates, Perfumery chemicals, Textile dyes Others Agribiotech, Food products, Services 4. Following items are included in other income: (` cr) No. Particulars Quarter ended on Year ended on June 30, 2021 March 31, 2021 June 30, 2020 March 31, 2021 Unaudited Unaudited Unaudited Audited a) Exchange rate difference - gain / (loss) 5.58 1.49 (0.76) (8.41) b) Dividend - - 30.69 56.63 5. The Group has considered possible effects that may result from the COVID-19 pandemic in preparation of these consolidated financial results including recoverability of inventories, trade receivables and other assets. In developing the assumptions relating to future uncertainties in the economic conditions due to the COVID-19 pandemic, it has, at the date of approval of these consolidated financial results, used relevant internal and external sources of information, including economic forecasts and expects that the carrying amounts of these assets are recoverable. The impact of the COVID-19 pandemic, including the current situation, may be different from that estimated as at the date of approval of these consolidated financial results. 6. The Parliament of India has approved the Code on Social Security, 2020 (the Code), which may impact the contributions by the Company towards provident fund, gratuity and ESIC. The Ministry of Labour and Employment has released draft rules for the Code on November 13, 2020. Final rules are yet to be notified. The Company will assess the impact of the Code when it comes into effect and will record related impact, if any. 7. The figures for the quarter ended March 31, 2021, are the balancing figures between audited figures in respect of the full financial year and the published year to-date figures up to the third quarter of the respective financial year. Other Expenses 1469400000.00 Power, fuel and water 992200000.00 Life Science Chemicals 3524900000.00 Others 147000000.00 Performance Chemicals 7535100000.00 11207000000.00 405000000.00 10802000000.00 Life Science Chemicals 492900000.00 Others 35200000.00 Performance Chemicals 1563300000.00 2091400000.00 20600000.00 -152700000.00 2223500000.00 Life Science Chemicals 9127000000.00 Others 1714700000.00 Performance Chemicals 20798400000.00 31640100000.00 20459800000.00 52099900000.00 Life Science Chemicals 2700900000.00 Others 362500000.00 Performance Chemicals 5441600000.00 8505000000.00 2069600000.00 10574600000.00